ARCHIVES

Bevacizumab And Irinotecan May Increase Survival Of GBM

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

ACS President Calls On Physicians To Take Advantage Of “Untapped Opportunities” In Cancer Prevention

March 27, 1987

Tom King To Leave NCI For Kennedy Ethics Institute; Cal Baldwin To Take NIH Job

June 27, 1980

DCPC Board Defers Decision On Hepatitis Vaccine Study, Rejects PAP Sensitivity Concepts

June 1, 1984

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

July 3, 1992

Rabson’s Group Hears Suggestions On Carcinogenesis

November 25, 1977

Two-Week Break Balances RT Palliation, Side Effects

February 26, 2010